FindTrial
Sign In

A non-interventional study in participants (patients) with confirmed fibrosis in chronic liver disease (as a regular diagnosis process by physician) to develop advanced Magnetic Resonance Imaging (MRI) Based Biomarker models for Detecting Fibrosis and Classifying Fibrosis Stage in Adults.

Development of a Magnetic Resonance Imaging (MRI) Based Biomarker for Detecting Fibrosis and Classifying Fibrosis Stage in Adults with Biopsy Proven Chronic Liver Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090059
Enrollment
150
Registered
2025-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

Intervention1: Nil: Nil

Sponsors

Resonance Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known diagnosis of chronic liver disease

Exclusion criteria

Exclusion criteria: Inadequate biopsy length for histology

Design outcomes

Primary

MeasureTime frame
Relationship between liver fibrosis assessment using analysed Magnetic Resonance Imaging (MRI) parameters for detection and staging of liver fibrosisTimepoint: Within 183 days of confirmed fibrosis in CLD patients—

Secondary

MeasureTime frame
To determine thresholds optimising the sensitivity of Liver Fibrosis-MRI to screen patients & optimising specificity to confirm liver fibrosis stageTimepoint: Within 183 days of confirmed fibrosis in CLD patients.—

Countries

India, Malaysia

Contacts

Public ContactNagaraj Vayyavuru

Vichag Limited

smileynagaraj@gmail.com8147496004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026